Insmed | INSM - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Cytokinetics USD 129.84M 7.32M 2026-03
DBV Technologies USD 229.2M 35.03M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Heron Therapeutics USD 26.12M 2.53M 2026-03
Insmed USD 582.19M 71.74M 2026-03
Novartis USD 6.88B 2.68B 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03